Recruiting Geographic Atrophy Studies in Fullerton
About Geographic Atrophy Clinical Trials in Fullerton
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
There are currently 2 geographic atrophy clinical trials recruiting participants in Fullerton, CA. These studies are seeking a combined 2,370 participants. Research is being sponsored by AstraZeneca, Apellis Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Geographic Atrophy Clinical Trials in Fullerton — FAQ
Are there geographic atrophy clinical trials in Fullerton?
Yes, there are 2 geographic atrophy clinical trials currently recruiting in Fullerton, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Fullerton?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fullerton research site will contact you about next steps.
Are clinical trials in Fullerton free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fullerton studies also compensate for your time and travel.
What geographic atrophy treatments are being tested?
The 2 active trials in Fullerton are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.
Data updated October 15, 2026 from ClinicalTrials.gov